CoChat
Cited by 61

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

MicroRNA-223-3p modulates dendritic cell function and ameliorates experimental autoimmune myocarditis by targeting the NLRP3 inflammasome

Chen, Liangqi, Hou, Xinyu, Zhang, Maomao, Zheng, Yang, Zheng, Xianghui, Yang, Qingyuan, Li, Jing, Gu, Nan, Zhang, Min, Sun, Yong, Wu, Jian, Yu, Bo · 2020 · Molecular Immunology

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.molimm.2019.10.027

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 48

  1. Arbore, 2016, T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells, Science, 352, 10.1126/science.aad1210 · DOI · Paper page
  2. Arend, 2008, IL-1, IL-18, and IL-33 families of cytokines, Immunol. Rev., 223, 20, 10.1111/j.1600-065X.2008.00624.x · DOI · Paper page
  3. Arnold, 2017, NLRP3 controls the development of gastrointestinal CD11b(+) dendritic cells in the steady state and during chronic bacterial infection, Cell Rep., 21, 10.1016/j.celrep.2017.12.015 · DOI
  4. Artlett, 2017, Mir-155 is overexpressed in systemic sclerosis fibroblasts and is required for NLRP3 inflammasome-mediated collagen synthesis during fibrosis, Arthritis Res. Ther., 19, 144, 10.1186/s13075-017-1331-z · DOI
  5. Bao Chai, 2019, MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1, Am. J. Transl. Res., 11
  6. Bartel, 2009, MicroRNAs: target recognition and regulatory functions, Cell, 136, 215, 10.1016/j.cell.2009.01.002 · DOI · Paper page
  7. Bros, 2018, Differentially tolerized mouse antigen presenting cells share a common miRNA signature including enhanced mmu-miR-223-3p expression which is sufficient to imprint a protolerogenic state, Front. Pharmacol., 9, 915, 10.3389/fphar.2018.00915 · DOI · Paper page
  8. Chen, 2012, Inducible microRNA-223 down-regulation promotes TLR-triggered IL-6 and IL-1beta production in macrophages by targeting STAT3, PLoS One, 7, e42971, 10.1371/journal.pone.0042971 · DOI · Paper page
  9. Dunaeva, 2018, Circulating serum miR-223-3p and miR-16-5p as possible biomarkers of early rheumatoid arthritis, Clin. Exp. Immunol., 193, 376, 10.1111/cei.13156 · DOI · Paper page
  10. Florez-Grau, 2018, Tolerogenic dendritic cells as a promising antigen-specific therapy in the treatment of multiple sclerosis and neuromyelitis optica from preclinical to clinical trials, Front. Immunol., 9, 1169, 10.3389/fimmu.2018.01169 · DOI
  11. Fulci, 2010, miR-223 is overexpressed in T-lymphocytes of patients affected by rheumatoid arthritis, Hum. Immunol., 71, 206, 10.1016/j.humimm.2009.11.008 · DOI · Paper page
  12. Goschl, 2019, Treg cells in autoimmunity: from identification to Treg-based therapies, Semin. Immunopathol., 10.1007/s00281-019-00741-8 · DOI · Paper page
  13. Halushka, 2019, Opportunities for microRNAs in the crowded field of cardiovascular biomarkers, Annu. Rev. Pathol., 14, 211, 10.1146/annurev-pathmechdis-012418-012827 · DOI · Paper page
  14. Haneklaus, 2012, Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1beta production, J. Immunol., 189, 10.4049/jimmunol.1200312 · DOI · Paper page
  15. Haneklaus, 2013, miR-223: infection, inflammation and cancer, J. Intern. Med., 274, 215, 10.1111/joim.12099 · DOI · Paper page
  16. Honarpisheh, 2016, Regulated necrosis-related molecule mRNA expression in humans and mice and in murine acute tissue injury and systemic autoimmunity leading to progressive organ damage, and progressive fibrosis, Biosci. Rep., 36, 10.1042/BSR20160336 · DOI
  17. Hongo, 2017, Tolerogenic interactions between CD8(+) dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts, Blood, 129, 10.1182/blood-2016-07-723015 · DOI
  18. Iannantuoni, 2018, Does Glycemic Control Modulate the Impairment of NLRP3 Inflammasome Activation in Type 2 Diabetes?, Antioxid. Redox Signal., 30, 232, 10.1089/ars.2018.7582 · DOI
  19. Jaen, 2009, Dendritic cells modulated by innate immunity improve collagen-induced arthritis and induce regulatory T cells in vivo, Immunology, 126, 35, 10.1111/j.1365-2567.2008.02875.x · DOI
  20. Kai Huang, 2014, MiR-223 suppresses endometrial carcinoma cells proliferation by targeting IGF-1R, Am. J. Transl. Res., 6, 841
  21. Ke, 2009, Anti-inflammatory role of IL-17 in experimental autoimmune uveitis, J. Immunol., 182, 3183, 10.4049/jimmunol.0802487 · DOI
  22. Liu, 2008, Control of protein synthesis and mRNA degradation by microRNAs, Curr. Opin. Cell Biol., 20, 214, 10.1016/j.ceb.2008.01.006 · DOI · Paper page
  23. Luo, 2019, MiR-223-3p functions as a tumor suppressor in lung squamous cell carcinoma by miR-223-3p-mutant p53 regulatory feedback loop, J. Exp. Clin. Cancer Res., 38
  24. Magnani, 2006, Myocarditis, Circulation, 113, 876, 10.1161/CIRCULATIONAHA.105.584532 · DOI · Paper page
  25. Mahnke, 2007, Tolerogenic dendritic cells and regulatory T cells: a two-way relationship, J. Dermatol. Sci., 46, 159, 10.1016/j.jdermsci.2007.03.002 · DOI · Paper page
  26. Maldonado, 2010, How tolerogenic dendritic cells induce regulatory T cells, Adv. Immunol., 108, 111, 10.1016/B978-0-12-380995-7.00004-5 · DOI · Paper page
  27. Metzger, 2011, Myocarditis: a defect in central immune tolerance?, J. Clin. Invest., 121, 1251, 10.1172/JCI57211 · DOI
  28. O’Connell, 2010, Physiological and pathological roles for microRNAs in the immune system, Nat. Rev. Immunol., 10, 111, 10.1038/nri2708 · DOI · Paper page
  29. Okuhara, 2012, Changes in microRNA expression in peripheral mononuclear cells according to the progression of osteoarthritis, Mod. Rheumatol., 22, 446, 10.3109/s10165-011-0536-2 · doi:10.3109/s10165-011-0536-2
  30. Osorio, 2015, Role of dendritic cells in the induction of lymphocyte tolerance, Front. Immunol., 6
  31. Patel, 2018, Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17/Treg axis, Int. Immunopharmacol., 54, 375, 10.1016/j.intimp.2017.11.026 · DOI
  32. Penna, 2007, 1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells, J. Immunol., 178, 145, 10.4049/jimmunol.178.1.145 · DOI · Paper page
  33. Phillips, 2017, Clinical tolerogenic dendritic cells: exploring therapeutic impact on human autoimmune disease, Front. Immunol., 8, 10.3389/fimmu.2017.01279 · DOI
  34. Quan, 2019, Amlexanox attenuates experimental autoimmune encephalomyelitis by inhibiting dendritic cell maturation and reprogramming effector and regulatory T cell responses, J. Neuroinflammation, 16, 52, 10.1186/s12974-019-1438-z · DOI
  35. Robert M. Friedlander, 1996, Functional role of IL-1β in IL-1β-converting enzyme-mediated apoptosis, J. Exp. Med., 184, 717, 10.1084/jem.184.2.717 · DOI · Paper page
  36. Schaefer, 2011, Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon, J. Immunol., 187, 10.4049/jimmunol.1100922 · DOI
  37. Shen, 2018, NLRP3: a promising therapeutic target for autoimmune diseases, Autoimmun. Rev., 17, 694, 10.1016/j.autrev.2018.01.020 · DOI · Paper page
  38. Steinman, 1973, Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution, J. Exp. Med., 137, 1142, 10.1084/jem.137.5.1142 · DOI · Paper page
  39. Sugawara, 2018, Dual strands of the miR-223 duplex (miR-223-5p and miR-223-3p) inhibit cancer cell aggressiveness: targeted genes are involved in bladder cancer pathogenesis, J. Hum. Genet., 63, 657, 10.1038/s10038-018-0437-8 · DOI
  40. Sun, 2017, NLRP3 inflammasome activation contributes to VSMC phenotypic transformation and proliferation in hypertension, Cell Death Dis., 8, e3074, 10.1038/cddis.2017.470 · DOI · Paper page
  41. Sun, 2019, miR-142 controls metabolic reprogramming that regulates dendritic cell activation, J. Clin. Invest., 130
  42. Svajger, 2018, Induction of tolerogenic dendritic cells by endogenous biomolecules: an update, Front. Immunol., 9, 2482, 10.3389/fimmu.2018.02482 · DOI
  43. Williams, 2010, The role of NOD-like Receptors in shaping adaptive immunity, Curr. Opin. Immunol., 22, 34, 10.1016/j.coi.2010.01.004 · DOI
  44. Wu, 2015, miR-10a inhibits dendritic cell activation and Th1/Th17 cell immune responses in IBD, Gut, 64, 10.1136/gutjnl-2014-307980 · DOI
  45. Yan, 2016, Inhibition of microRNA-155 ameliorates experimental autoimmune myocarditis by modulating Th17/Treg immune response, J. Mol. Med., 94, 1063, 10.1007/s00109-016-1414-3 · DOI
  46. Yang, 2016, MicroRNA-17 modulates regulatory t cell function by targeting Co-regulators of the Foxp3 transcription factor, Immunity, 45, 83, 10.1016/j.immuni.2016.06.022 · DOI
  47. Yang, 2015, Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics, Adv. Drug Deliv. Rev., 81, 62, 10.1016/j.addr.2014.10.029 · DOI · Paper page
  48. Zhuang, 2012, A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation, Circulation, 125, 2892, 10.1161/CIRCULATIONAHA.111.087817 · DOI · Paper page

Cited by

Metadata

Authors
Chen, L., Hou, X., Zhang, M., Zheng, Y., Zheng, X., Yang, Q., Li, J., Gu, N., Zhang, M., Sun, Y., Wu, J., & Yu, B.
Venue
Molecular Immunology
Publisher
Elsevier BV
Published
2020-01
Volume
117
Pages
73-83
ISSN
0161-5890
Cited by
61
References
8
Language
en
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
  • Key Laboratory of Myocardial Ischemia, Ministry of Education
  • Harbin Medical University
  • National Natural Science Foundation of China (81670373, 81670459, 81771846)
  • Ministry of Education of the People's Republic of China (KF201716, KF201806, KF201822)
  • National Key Research and Development Program of China (2016YFC1301100)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.